Interview: Juan López-Belmonte, CEO, Laboratorios Rovi, Spain
Since PharmaBoardroom interviewed Juan López-Belmonte, CEO of Rovi, in 2008, the market has changed drastically.…
Laboratorios Rovi
Last updated: 16.06.2014
ROVI is a fully integrated Spanish specialty pharmaceutical company engaged in the research, development, in-licensing, manufacturing and marketing of small molecule and specialty biologic drugs.
The Company has a diversified portfolio of products that it markets in Spain through its specialized sales force, calling on specialist physicians, hospitals and pharmacies. ROVI’s portfolio of 30 principal marketed products is currently anchored by the internally-developed, second generation low molecular weight heparin, Bemiparin.
ROVI’s research and development pipeline is focused primarily on the expansion of applications, indications and alternative mechanisms of action for the heparin-derived products and other glycosaminoglycans and on the development of new controlled release mechanisms based on ISMTM technology, with the aim of obtaining new pharmaceutical products that enable the regular administration of formulations which are administered daily in chronic and prolonged treatments.
ROVI manufactures the active biological ingredient (Bemiparin) for its principal proprietary products and for injectable pharmaceutical products developed by its own in-house research team, and utilizes its state-of-the-art filling and packaging capabilities to provide a broad array of toll manufacturing services to leading international pharmaceutical companies, primarily in the area of pre-filled syringes. In addition, ROVI provides contract manufacturing and packaging services of solid oral pharmaceutical dosage forms, using the most enhanced technology, Roller Compaction.
Additional information about ROVI is available on the company’s website: www.rovi.es
LABORATORIOS FARMACÉUTICOS ROVI
| C/ Alfonso Gómez, 45 |
| 28037, Madrid |
| Tel: |
| Fax: (+34) 913 047 881 |
| e-mail: rovi@rovi.es |
Interviews
Related
María Jesús Lamas – Director & César Hernández García, Head,…
María Jesús Lamas, director and César Hernández García, head of medicines for human use at the Spanish Agency…
Staffan Schüberg – CEO, Esteve, Spain
Staffan Schüberg, CEO of Esteve, highlights the restructure of the company as it moves towards its new age of…
Sergio Rodriguez – CEO, Pfizer Spain
Sergio Rodriguez, CEO of Pfizer Spain, highlights the strength of the affiliate and the importance for the company…
Juan Abarca Cidón – President, HM Hospitales, Spain
Dr Juan Abarca Cidón, president of HM Hospitales, one of Spain’s leading private health groups, gives insight…
Damaso Molero – General Manager, 3P Biopharmaceuticals, Spain
Damaso Molero, general manager of 3P Biopharmaceuticals, a leading Spanish CDMO, highlights the growth of the…
Antonio Alarco – Senator Elect of Tenerife; Former Health Spokesperson,…
Dr Antonio Alarco gives his insider take on the future of Spanish healthcare, personalized medicine, and the areas…
Daniel-Anibal Garcia Diego – President, FEDHEMO, Spain
Daniel-Anibal Garcia Diego, president of the Spanish Haemophilia Federation (FEDHEMO), discusses the current…
Alfonso Beltrán García-Echániz – Director, FIPSE, Spain
Alfonso Beltrán García-Echániz, director of the Spanish Foundation for Innovation and Prospective Health…
Antonio Lopez – CEO & Diego Monux – Founding Partner, SILO, Spain
Antonio Lopez and Diego Monux, CEO and founding partner of SILO (Science and Innovation Link Office), talk about…
Marieta Jiménez – President and General Manager, Merck Spain
Marieta Jiménez, president and general manager of Merck Spain, highlights her three top priorities: innovation,…
Inês Barata Correia – General Manager Iberia, HRA Pharma, Spain
Inês Correia, general manager of the Iberia affiliate of HRA Pharma, a fast-growing consumer healthcare company…
Eduardo Barriga – General Manager, Boiron Spain
Eduardo Barriga, general manager of Boiron, the homeopathic market leader in Spain, discusses the company’s…
